Number of shares and votes in Active Biotech

Feb 28, 2011 10:30 (CET) 
The number of shares and votes in Active Biotech has changed as a result of the
exercise of employee stock options and the private placement with international
institutional investors and qualified investors in Sweden.

Today, the last trading day of the month, there are in total 68,582,691 shares
and votes in Active Biotech.


Lund, February 28, 2011
Active Biotech AB (publ)


For further information, please contact:
Hans Kolam, CFO
Tel: +46 (0)46 19 20 44
E-mail: hans.kolam@activebiotech.com



About Active Biotech
Active  Biotech AB  (NASDAQ OMX  NORDIC: ACTI)  is a  biotechnology company with
focus  on autoimmune/inflammatory diseases  and cancer. Projects  in or entering
pivotal  phase are laquinimod, an orally administered small molecule with unique
immunomodulatory  properties for the  treatment of multiple  sclerosis, TASQ for
prostate  cancer and  ANYARA for  use in  cancer targeted  therapy, primarily of
renal  cell  cancer.  In  addition,  laquinimod  is  in Phase II development for
Crohn's  and Lupus.  Further projects  in clinical  development comprise the two
orally  administered compounds, 57- 57 for SLE and Systemic Sclerosis as well as
RhuDex(TM) for RA. Please visit www.activebiotech.com  for more information.

Active Biotech AB
PO Box 724, SE-220 07 Lund
Sweden
Tel: +46 (0)46-19 20 00
Fax: +46 (0)46-19 11 00


Active  Biotech  is  required  under  the  Securities  Markets  Act  to make the
information  in this  press release  public. The  information was  submitted for
publication at 10:30 am CET on February 28, 2011.



Number of shares and votes in Active Biotech:
http://hugin.info/1002/R/1492744/428545pdf




This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
    other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
     originality of the information contained therein.

Source: Active Biotech via Thomson Reuters ONE

[HUG#1492744]